Cargando…
Setomimycin as a potential molecule for COVID‑19 target: in silico approach and in vitro validation
ABSTRACT: COVID-19 pandemic caused by the SARS-CoV-2 virus has led to a worldwide crisis. In view of emerging variants time to time, there is a pressing need of effective COVID-19 therapeutics. Setomimycin, a rare tetrahydroanthracene antibiotic, remained unexplored for its therapeutic uses. Herein,...
Autores principales: | Manhas, Ravi S., Tiwari, Harshita, Noor, Mateen, Ahmed, Ajaz, Vishwakarma, Jyoti, Tripathi, Raja B. M., Ramachandran, Ravishankar, Madishetti, Sreedhar, Mukherjee, Debaraj, Nargotra, Amit, Chaubey, Asha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136828/ https://www.ncbi.nlm.nih.gov/pubmed/35622309 http://dx.doi.org/10.1007/s11030-022-10441-5 |
Ejemplares similares
-
Correction to: Setomimycin as a potential molecule for COVID‑19 target: in silico approach and in vitro validation
por: Manhas, Ravi S., et al.
Publicado: (2022) -
A biostatistical approach for augmenting rare bianthraquinone antibiotic production by Streptomyces sp. RA-WS2 using Taguchi design
por: Manhas, Ravi Singh, et al.
Publicado: (2022) -
Correction: Conversion of N-acyl amidines to amidoximes: a convenient synthetic approach to molnupiravir (EIDD-2801) from ribose
por: Ahmed, Ajaz, et al.
Publicado: (2022) -
Conversion of N-acyl amidines to amidoximes: a convenient synthetic approach to molnupiravir (EIDD-2801) from ribose
por: Ahmed, Ajaz, et al.
Publicado: (2021) -
Palladium catalysed carbonylation of 2-iodoglycals for the synthesis of C-2 carboxylic acids and aldehydes taking formic acid as a carbonyl source
por: Ahmed, Ajaz, et al.
Publicado: (2019)